0001493152-22-018684.txt : 20220706
0001493152-22-018684.hdr.sgml : 20220706
20220706161558
ACCESSION NUMBER: 0001493152-22-018684
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220701
FILED AS OF DATE: 20220706
DATE AS OF CHANGE: 20220706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDREWS DEBORAH J
CENTRAL INDEX KEY: 0001325697
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 221068885
MAIL ADDRESS:
STREET 1: 1911 WALKER AVE.
CITY: MONROVIA
STATE: CA
ZIP: 91016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc.
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTIME INC
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0306
4
2022-07-01
0
0000876343
Lineage Cell Therapeutics, Inc.
LCTX
0001325697
ANDREWS DEBORAH J
C/O LINEAGE CELL THERAPEUTICS
2173 SALK AVENUE, SUITE 200
CARLSBAD
CA
92008
1
0
0
0
Stock Option (right to buy)
1.57
2022-07-01
4
A
0
50000
0
A
2032-07-01
Common Shares
50000
50000
D
Will vest and become exercisable on July 1, 2023, subject to the reporting person's continuous service with the issuer.
/s/ Grant Harbert, as Attorney-in-Fact
2022-07-06